Currently holds positions in CVS Health Corp and Boston Scientific Corp
Position | Company | Period |
---|---|---|
Independent Director | CVS Health Corp | Nov. 1, 2018 - |
Lead Independent Director | Boston Scientific Corp | April 15, 2016 - |
Lead Independent Director | Aetna Inc | Feb. 24, 2012 - Nov. 28, 2018 |
Independent Director | Xylem Inc | Oct. 31, 2011 - May 9, 2017 |
Independent Director | Boston Scientific Corp | March 1, 2014 - April 15, 2016 |
Executive Chairman of the Board | Becton Dickinson and Co | Oct. 1, 2011 - July 1, 2012 |
Independent Director | Aetna Inc | June 27, 2003 - Feb. 24, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-05-02 | 2024-05-02 |
CVS Health Corp
(CVS)
|
B Purchase |
1,000
+4.8%
53.8853,879 USD |
1,000 +4.8% | 53.88 | 53,879 USD | |
2024-04-29 | 2024-04-26 |
Boston Scientific Corp
(BSX)
|
S Sale |
9,818
-19.2%
73.29719,562 USD |
9,818 -19.2% | 73.29 | 719,562 USD | |
2024-02-14 | 2024-02-13 |
Boston Scientific Corp
(BSX)
|
S Sale |
7,000
-14.5%
65.03455,223 USD |
7,000 -14.5% | 65.03 | 455,223 USD | |
2023-11-06 | 2023-11-03 |
CVS Health Corp
(CVS)
|
B Purchase |
2,000
+10.7%
70.47140,930 USD |
2,000 +10.7% | 70.47 | 140,930 USD | |
2022-02-11 | 2022-02-10 |
CVS Health Corp
(CVS)
|
B Purchase |
1,000
+5.8%
105.90105,904 USD |
1,000 +5.8% | 105.90 | 105,904 USD | |
2021-02-17 | 2021-02-17 |
CVS Health Corp
(CVS)
|
B Purchase |
3,000
+26.5%
72.00216,000 USD |
3,000 +26.5% | 72.00 | 216,000 USD | |
2019-03-11 | 2019-03-08 |
CVS Health Corp
(CVS)
|
B Purchase |
2,000
+37.2%
52.80105,600 USD |
2,000 +37.2% | 52.80 | 105,600 USD | |
2019-03-04 | 2019-03-01 |
CVS Health Corp
(CVS)
|
B Purchase |
4,000
+290.3%
58.27233,080 USD |
4,000 +290.3% | 58.27 | 233,080 USD | |
2004-07-01 | 2004-07-01 |
Becton Dickinson and Co
(BDX)
|
PS Planned sale |
19,000
-18.1%
49.59942,210 USD |
19,000 -18.1% | 49.59 | 942,210 USD |